Pharma.
Submissions, clean.
Pharma operators run trials, regulatory submissions, adverse-event tracking and literature review under intense audit pressure. Optale gives every agent action a trace and every approval a human, in a posture that matches what the sector's regulators expect to see.
What's broken today.
03 · PAIN POINTSTrials, regulatory comms and adverse-event tracking live in audit-heavy silos.
Submissions reconstruct evidence rather than referencing it.
Literature review is manual when the corpus is enormous.
The operating layer in pharma.
05 · SCHEMA- Trials
- Regulatory
- Adverse events
- Literature
- parse
- reconcile
- type
- govern
- memory
- graph
- time
- relations
- Trial-agent
- Safety-agent
- Regulatory-agent
- Shorter submission cycles.
What it looks like.
03 · USE CASES- USE · 01
Submission drafts
Regulatory-agents draft submissions referencing trial data, prior interactions and current guidance, with every claim sourced.
- USE · 02
Adverse event triage
Safety-agents classify reports, flag patterns and route material findings to humans with the evidence trail intact.
- USE · 03
Literature watch
Trial-agents track relevant literature daily, surface what changes the trial picture and link straight to source.